MedTrace Logo

Vitamin D Supplementations as Adjunct to Anti-Tuberculosis Drugs in Mongolia

NCT01657656 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2014-07-30

No results posted yet for this study

Summary

Hypothesis

That improving vitamin D status among TB patients will speed the pace of bacteriological cure, and will enhance immune responses to TB infection

Conditions

  • Vitamin D Supplements
  • Tuberculosis
  • Sputum
  • Cytokines
  • Immunity

Interventions

DIETARY_SUPPLEMENT

Vitamin D

Sponsors & Collaborators

  • Harvard School of Public Health (HSPH)

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-05-31
Completion
2014-07-31

Countries

  • Mongolia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01657656 on ClinicalTrials.gov